Cannabis Investment Opportunities: Vanguard Mutual Fund Options

Marijuana ETFs (exchange-traded funds) allow investors to invest in a range of cannabis-related companies. Vanguard Mutual Fund, the world's largest mutual fund company, revealed in an SEC filing that it has invested in the three largest Canadian cannabis producers: Aphria, Aurora Cannabis, and Canopy Growth. With a total investment of approximately $47 million, Vanguard's move reflects the growing acceptance of cannabis in the public eye due to its potential therapeutic and healing benefits. As the legal cannabis industry matures, index funds and mutual funds are expected to play a larger role as owners of cannabis stocks.

Vanguard's $110 billion Developed Market Index Fund

The Vanguard Group, Inc., commonly known as Vanguard, is an American investment advisor company founded in 1975 and based in Malvern, Pennsylvania. With about $9.3 trillion in global assets under management as of May 2024, Vanguard is the largest provider of mutual funds in the world and the second-largest provider of exchange-traded funds (ETFs).

These investments represent a small portion of the fund's total value but are significant in the context of the emerging legal cannabis industry. Vanguard's involvement underscores the potential for index funds and mutual funds to play an increasingly prominent role in this sector as it matures. The fund's strategy is to match the performance of a diversified group of stocks from large, mid, and small-cap companies in Canada and major markets in Europe and the Pacific region.

Vanguard's structure as a company owned by its funds, which are in turn owned by its shareholders, allows it to maintain low expense ratios for its funds. This structure also enables Vanguard to prioritise the needs of investors and avoid potential conflicts of interest that may arise in publicly traded investment management firms.

SEC filing reveals investment in 3 Canadian cannabis companies

An SEC filing has revealed that Vanguard's $110 billion Developed Market Index Fund has invested in the three largest Canadian cannabis producers. The filing shows ownership in Aphria, Aurora Cannabis and Canopy Growth.

The investments represent approximately $47 million, which is a small part of the fund’s total value. However, the stakes represent about 0.4% of the overall market capitalization of the three companies.

As the global legal cannabis industry matures, index funds and mutual funds are likely to play an increasingly larger role as owners of the stocks.

Cannabis stocks: Aphria, Aurora Cannabis, Canopy Growth

In 2018, Vanguard's $110 billion Developed Market Index Fund revealed in an SEC filing that it had invested in three Canadian cannabis producers: Aphria, Aurora Cannabis, and Canopy Growth.

Aphria

Aphria is a Canadian cannabis company that trades on the Toronto Stock Exchange (TSX) under the ticker symbol APH and on the OTC market as APHQF. As of March 2021, its shares were experiencing volatility, with a 6.4% decline posted on a single day.

Aurora Cannabis

Aurora Cannabis Inc. is a Canadian company that cultivates and sells medicinal and recreational cannabis through various brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. It is headquartered in Edmonton, Canada, and its NasdaqCM stock symbol is ACB. Its stock has experienced ups and downs, with rises and falls posted on consecutive days in late February 2024.

Canopy Growth

Canopy Growth is a Canadian cannabis company that trades on the TSX as WEED and on the NYSE as CGC. It engages in research and product development and is one of the companies in which Vanguard's Developed Market Index Fund has invested.

The global legal cannabis industry is still maturing, and as it does, index funds and mutual funds will likely play an increasingly larger role as owners of cannabis stocks.

Marijuana ETFs: risks and rewards

Overview

The legalisation of marijuana has created a new industry with ample opportunities for investment and growth. Marijuana exchange-traded funds (ETFs) allow investors to invest in a range of cannabis-related companies, from product development to distribution. However, investing in this nascent industry comes with significant risks and uncertainties.

Risks

Regulatory and Political Challenges: Marijuana ETFs face challenges due to the evolving legal landscape surrounding marijuana. While some US states have legalised marijuana for medical or recreational purposes, it remains illegal at the federal level. This discrepancy creates regulatory uncertainties and makes banks hesitant to back ETFs linked to the cannabis industry.

Reputation and Legal Risks: Banks are concerned about the potential legal and reputation-related risks associated with backing ETFs that track stocks in an industry that remains illegal at the federal level. This has resulted in setbacks and tensions between ETF managers and custodian banks.

Volatility and Unpredictability: The cannabis industry is new and volatile, with constantly changing legal, financing, and operational landscapes. Marijuana stocks and ETFs are subject to significant price fluctuations and unpredictable performance.

Limited Growth and Trading Concerns: Some marijuana ETFs have faced challenges with trading volumes and inflows, with a dip in performance in 2018 due to shifting legal statuses and issues with legalisation.

Rewards

Diversification: Investing in marijuana ETFs allows for risk diversification across multiple companies and segments of the industry, rather than concentrating risk in a single stock.

Growth Potential: The legal marijuana industry is a nascent space with tremendous growth potential. As the industry matures, index funds and mutual funds are likely to play a larger role as owners of cannabis stocks.

Early Investment Opportunity: Investing in marijuana ETFs provides an opportunity to get in at an extremely early stage of the industry's development. If the legal marijuana industry takes off, early investors may benefit from significant returns.

Investing in marijuana ETFs comes with considerable risks due to regulatory uncertainties, reputation concerns, and industry volatility. However, it also offers the potential for diversification, early entry into a high-growth industry, and significant returns if the industry succeeds in the long term. Investors need to carefully consider their risk tolerance and conduct thorough research before investing in this unpredictable sector.

Cannabis stocks and the US legal landscape

Cannabis stocks have been impacted by the legal landscape in the US, which has both upside potential and uncertainty. While cannabis is now legal in 37 states for medical use and 23 states for recreational use, it remains illegal at the federal level, classified alongside heroin, ecstasy, and LSD. This discrepancy between state and federal laws creates a complex environment for investors.

The US legal landscape has presented challenges and opportunities for the cannabis industry. On the one hand, the federal prohibition has restricted access to financial services for cannabis businesses, making it difficult to secure capital from banks or financial institutions. This has led to alternative funding options, such as real estate investment trusts (REITs) like Innovative Industrial Properties, which buy properties from cannabis operators and lease them back, providing much-needed cash to the operators.

On the other hand, the US Department of Health and Human Services' recommendation to ease restrictions on marijuana in August 2024 provided a boost to cannabis stocks, highlighting the potential upside of regulatory changes. Additionally, the US Drug Enforcement Administration's (DEA) move to reclassify marijuana from a Schedule 1 controlled substance to Schedule 3, recognising its medical use and lower potential for abuse, is expected to further drive growth in the industry.

The legal landscape also varies at the state level, with 46 states enacting different legalization regimes, creating a patchwork of regulations that businesses must navigate. This dynamic environment, with ongoing legalisation efforts and shifting public opinion, presents opportunities for investors willing to take on the associated risks.

Investing in cannabis stocks comes with unique risks and considerations. The legal and political risks, as well as financial constraints due to federal prohibition, cannot be overlooked. Additionally, the rapidly growing industry is prone to supply and demand irregularities, and most cannabis companies carry large debt burdens and face profitability challenges. The volatility of the industry, combined with the small market caps of many cannabis companies, makes this sector a high-risk, high-reward proposition for investors.

Despite the risks, the legal cannabis industry is expected to grow significantly. Global spending on legal cannabis is projected to reach $57 billion in a decade, with legal cannabis revenue in the US alone expected to hit $23.4 billion by 2022. As the industry matures, index funds and mutual funds, such as Vanguard's investment in Canadian cannabis producers, are likely to play a larger role as owners of cannabis stocks.

Frequently asked questions